期刊文献+

利用cDNA微阵列研究胃肠间质瘤耐药、复发相关基因的表达 被引量:3

Analysis of recurrence-associated and imatinib resistance-associated gene expression in gastrointestinal stromal tumor by cDNA microarray
原文传递
导出
摘要 目的 观察复发与未复发胃肠间质瘤(GIST)间的基因表达差异,探讨恶性GIST伊马替尼耐药、复发发生发展机制.方法 收集5对患者的新鲜复发及未复发GIST组织随机配对成组行cDNA微阵列研究.应用荧光定量聚合酶链反应(PCR)方法对芯片结果进行验证.结果 复发与未复发GIST间的差异表达基因共1088个,其中表达上调者592个,下调者496个;上调基因功能主要与信号传导、肿瘤发生、药物代谢、细胞黏附等相关;下调基因功能则主要与细胞间隙连接通讯、肿瘤抑制、补体免疫防御等相关;GIST相关基因c-kit(CD117)、CD34在两组间差异均无统计学意义;荧光定量PCR验证结果与芯片表达结果一致.结论 运用cDNA芯片进行基因表达谱分析,有助于探讨GIST复发、伊马替尼耐药机制并寻找新的治疗靶标. Objective To study the differential expression of recurrence-associated and imatinib resistance-associated gene between recurrent and unrecurrent gastrointestinal stromal tumors (GIST) and explore the molecular mechanism of drug resistance and recurrence of malignant GIST by cDNA microarray analysis.Methods A total of 5 pairs of recurrent and unrecurrent fresh GIST tissues were subjected to cDNA microarray with 41000 genes.Array results were validated by reverse transcription-polymerase chain reaction (RT-PCR).Results There were 1088 differential expression genes between recurrent and unrecurrent GIST tissues,including 592 genes up-regulated and 496 down-regulated.Most of the overexpressed genes were related to signaling pathway,oncogenesis,drug metabolism,cell adhesion,and the down-regulated genes were related to gap junction,tumor suppression,complement imumune defense.GIST related genes (c-kit,CD34) had no significant difference between recurrent and unrecurrent GIST tissues.RT-PCR confirmed the aAbstract:Objective To study the differential expression of recurrence-associated and imatinib resistance-associated gene between recurrent and unrecurrent gastrointestinal stromal tumors (GIST) and explore the molecular mechanism of drug resistance and recurrence of malignant GIST by cDNA microarray analysis.Methods A total of 5 pairs of recurrent and unrecurrent fresh GIST tissues were subjected to cDNA microarray with 41000 genes.Array results were validated by reverse transcription-polymerase chain reaction (RT-PCR).Results There were 1088 differential expression genes between recurrent and unrecurrent GIST tissues,including 592 genes up-regulated and 496 down-regulated.Most of the overexpressed genes were related to signaling pathway,oncogenesis,drug metabolism,cell adhesion,and the down-regulated genes were related to gap junction,tumor suppression,complement imumune defense.GIST related genes (c-kit,CD34) had no significant difference between recurrent and unrecurrent GIST tissues.RT-PCR confirmed the array results.Conclusion Gene expression profiling by cDNA microarray analysis provides not only molecular understanding of recurrence mechanism and imatinib resistance mechanism of GIST,but may also be helpful in discovering new therapeutic targets for recurrent and imatinib resistant GIST.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第3期373-376,共4页 Chinese Journal of Experimental Surgery
基金 基金项目:温州市科技计划资助项目(Y20090289)
关键词 胃肠间质瘤 CDNA微阵列 复发 伊马替尼 Gastrointestinal stromal tumor cDNA microarray Recurrence Imatinib
  • 相关文献

参考文献5

  • 1Shoemaker DD,Schadt EE,Armour CD,et al.Experimental annotation of the hum an genome using microarray technology.Nature,2001,409:922-927.
  • 2van't Veer LJ,Dai H,van de Vijver MJ,et al.Gene expression profiling predicts clinical outcome of breast cancer.Nature,2002,415:530-536.
  • 3虞亦鸣,刘忠,邓在春,谭云山,徐永华.erbB4/HER4在结肠癌的表达[J].中华实验外科杂志,2008,25(11):1452-1453. 被引量:1
  • 4Eto K,Hommyo A,Yonemitsu R,et al.ErbB4 signals Neuregulinlstimulated cell proliferation and c-fos gene expression through phosphorylation of serum response factor by mitogen-activated protein kinase cascade.Mol Cell Biochem,2010,339:119-125.
  • 5Hollmén M,Elenius K.Potential of ErbB4 antibodies for cancer therapy.Future Onco1,2010,6:37-53.

二级参考文献8

  • 1Plowman GD, Culouscou JM, Whitney GS, et al. Ligand-specific activation of HER4/P180erbB4,a fourth member of the epidermal growth factor reeeptor family. Proe Natl Aead Sei USA, 1993,90 : 1746.
  • 2Jacobs TW, Gown AM, Yaziji H, et al. Specificity of Hercep Test in Determing Her-2/NEU Status of Breast Cancers Using the United States Food and Drug Administration-Approved Scoring System. Journal of Clinical Oncology, 1999,17 : 1983.
  • 3Lai C and Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron, 1991,6:691.
  • 4Srinivasan R, Poulsom R, Hurst HC, et al. Expression of the c-erbB-4/ HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol, 1998,185:236.
  • 5Kountourakis P, Pavlakis K, Psyrri A, et al. Prognostic significance of HER3 and HER4 protein expression in eoloreetal adenoeareinomas. BMC Cancer,2006,6:46.
  • 6Starr A, Greif J,Vexler A, et al. ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy. Int J Cancer,2006,119:269.
  • 7虞亦鸣,周浩杰,谭云山,徐永华,刘忠,邓在春.erbB4/HER4在胃癌的表达[J].中华实验外科杂志,2008,25(1):41-41. 被引量:7
  • 8邢传平,刘斌,董亮.免疫组织化学标记结果的判断方法[J].中华病理学杂志,2001,30(4):318-318. 被引量:206

同被引文献1

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部